Danazol
Back to searchMolecule Structure
Scientific Name
Danazol
Description of the Drug
Danazol is a synthetic steroid and pituitary gonadotropin inhibitor used in the treatment of endometriosis and symptomatic treatment of severe pain and tenderness associated with benign fibrocystic breasts.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01406
http://www.drugbank.ca/drugs/DB01406
Brand Name(s)
Danazol, Danocrine
Company Owner(s)
American Therapeutics Inc, Lannett Holdings Inc, Barr Laboratories Inc, Lannett Co Inc, Sanofi Aventis Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Androgen Receptor | SINGLE PROTEIN | AGONIST | CHEMBL1871 |
Progesterone receptor | SINGLE PROTEIN | AGONIST | CHEMBL208 |
Clinical Trial(s)
Unichem Links
Atlas | danazol | |
SureChEMBL | SCHEMBL21107 | |
PharmGKB | PA164749056 | |
Human Metabolome Database | HMDB0002835 | |
DrugBank | DB01406 | |
PubChem: Thomson Pharma | 14777802 | 14851335 |
PubChem | 28417 | |
Mcule | MCULE-5533294331 | |
LINCS | LSM-3073 | |
Nikkaji | J24.462G | |
PDBe | QA1 | |
BindingDB | 50423541 | |
EPA CompTox Dashboard | DTXSID2022880 | |
DrugCentral | 779 | |
Brenda | 56844 | |
ChemicalBook | CB9463336 | |
Guide to Pharmacology | 6942 | |
rxnorm | DANAZOL | |
PubChem: Drugs of the Future | 123055285 | |
ChEBI | 4315 | |
ZINC | ZINC000003881958 |